UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

European journal of neurology, 2013-01, Vol.20 (1), p.5-15

2013

Volltextzugriff (PDF)

Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD

Neurology, 2008-08, Vol.71 (7), p.474-480

2008

Volltextzugriff (PDF)

Argyrophilic grain disease in individuals younger than 75 years: clinical variability in an under‐recognized limbic tauopathy

European journal of neurology, 2020-10, Vol.27 (10), p.1856-1866

2020

Volltextzugriff (PDF)

Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson’s disease

Brain (London, England : 1878), 2010-03, Vol.133 (3), p.727-745

2010

Volltextzugriff (PDF)

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program

Parkinsonism & related disorders, 2015-10, Vol.21 (10), p.1133-1144

2015

Volltextzugriff (PDF)

Anticholinergics for symptomatic management of Parkinson's disease

Cochrane database of systematic reviews, 2003 (2), p.CD003735

2003

Volltextzugriff (PDF)

Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease

Journal of neurology, neurosurgery and psychiatry, 2004-12, Vol.75 (12), p.1749-1752

2004

Volltextzugriff (PDF)

Olfaction and Parkinson's syndromes: its role in differential diagnosis

Current opinion in neurology, 2004-08, Vol.17 (4), p.417-423

2004

Volltextzugriff (PDF)

Repetitive impulse-associated behavioral disorders in Parkinson's disease

Nervenarzt, 2012-12, Vol.83 (12), p.1582

2012

Volltextzugriff (PDF)

Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease

Journal of neurology, neurosurgery and psychiatry, 2006-03, Vol.77 (3), p.317-321

2006

Volltextzugriff (PDF)

Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease

Neurology, 2004-04, Vol.62 (7), p.1224-1226

2004

Volltextzugriff (PDF)

Levodopa in the treatment of Parkinson's disease: Current controversies

Movement disorders, 2004-09, Vol.19 (9), p.997-1005

2004

Volltextzugriff (PDF)

Apomorphine - pharmacological properties and clinical trials in Parkinson's disease

Parkinsonism & related disorders, 2016-12, Vol.33, p.S13-S21

2016

Volltextzugriff (PDF)

S.06.04 Depression in Parkinson's disease and its treatment

European neuropsychopharmacology, 2007, Vol.17, p.S184-S184

Katzenschlager, R

2007

Volltextzugriff (PDF)

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Lancet neurology, 2018-09, Vol.17 (9), p.749-759

2018

Volltextzugriff (PDF)

Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial

Neurology, 2001-11, Vol.57 (9), p.1687-1694

2001

Volltextzugriff (PDF)

The l-dopa response in vascular parkinsonism

Journal of neurology, neurosurgery and psychiatry, 2004-04, Vol.75 (4), p.545-547

2004

Volltextzugriff (PDF)

Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure

Neurology, 2007-08, Vol.69 (6), p.555-563

2007

Volltextzugriff (PDF)

Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy

Brain (London, England : 1878), 2002-05, Vol.125 (Pt 5), p.969-975

2002

Volltextzugriff (PDF)

Severity of chronic venous disorders and its relationship to the calf muscle pump

VASA, 2009-05, Vol.38 (2), p.171-176

2009

Volltextzugriff (PDF)

Low dose quetiapine for drug induced dyskinesias in Parkinson’s disease: a double blind cross over study

Journal of neurology, neurosurgery and psychiatry, 2004-02, Vol.75 (2), p.295-297

2004

Volltextzugriff (PDF)

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations

Parkinsonism & related disorders, 2015-09, Vol.21 (9), p.1023-1030

2015

Volltextzugriff (PDF)

Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome

Movement disorders, 2004-04, Vol.19 (4), p.397-405

2004

Volltextzugriff (PDF)

Incidence of pseudoaneurysm after diagnostic and therapeutic angiography

Radiology, 1995-05, Vol.195 (2), p.463-466

1995

Volltextzugriff (PDF)

1 – 25 von 108

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(100)
Mit Volltextzugriff
(72)

Publikationsform

Sprache

Englisch
(96)
Deutsch
(12)

Erscheinungsjahr

n.n

Thema

Science & Technology
(78)
Humans
(77)
Life Sciences & Biomedicine
(76)
Male
(57)
Female
(55)
Middle Aged
(50)
Biological And Medical Sciences
(48)
Medical Sciences
(46)
Neurosciences & Neurology
(44)
Aged
(43)
Clinical Neurology
(40)
Neurology
(33)
Adult
(27)
Parkinson's Disease
(26)
Aged, 80 And Over
(16)
Parkinson Disease - Drug Therapy
(15)
Risk Factors
(15)
Cardiovascular System & Cardiology
(14)
Neurosciences
(13)
Antiparkinson Agents - Therapeutic Use
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson's disease

Fourteen-year final report of the randomized PDRG-UK trial comparing three initial treatments in PD

EuroInf: A Multicenter Comparative Observational Study of Apomorphine and Levodopa Infusion in Parkinson's Disease

Argyrophilic grain disease in individuals younger than 75 years: clinical variability in an under‐recognized limbic tauopathy

Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson’s disease

Collective physician perspectives on non-oral medication approaches for the management of clinically relevant unresolved issues in Parkinson's disease: Consensus from an international survey and discussion program

Anticholinergics for symptomatic management of Parkinson's disease

Olfactory function distinguishes vascular parkinsonism from Parkinson’s disease

Olfaction and Parkinson's syndromes: its role in differential diagnosis

Repetitive impulse-associated behavioral disorders in Parkinson's disease

Relationship between impulsive sensation seeking traits, smoking, alcohol and caffeine intake, and Parkinson’s disease

Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease

Levodopa in the treatment of Parkinson's disease: Current controversies

Apomorphine - pharmacological properties and clinical trials in Parkinson's disease

S.06.04 Depression in Parkinson's disease and its treatment

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Ten-year follow-up of three different initial treatments in de-novo PD: a randomized trial

The l-dopa response in vascular parkinsonism

Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure

Pathological, clinical and genetic heterogeneity in progressive supranuclear palsy

Severity of chronic venous disorders and its relationship to the calf muscle pump

Low dose quetiapine for drug induced dyskinesias in Parkinson’s disease: a double blind cross over study

Expert Consensus Group report on the use of apomorphine in the treatment of Parkinson's disease – Clinical practice recommendations

Punding in Parkinson's disease: Its relation to the dopamine dysregulation syndrome

Incidence of pseudoaneurysm after diagnostic and therapeutic angiography

Suchergebnisse filtern